Potential Link Between Smoking, Vaping, and Increased Diabetes Risk
New research links smoking and vaping to higher risks of prediabetes and diabetes, emphasizing the need for public health efforts to reduce tobacco and e-cigarette use.
Recent research from the University of Georgia indicates that both smoking traditional cigarettes and vaping with e-cigarettes may significantly elevate the risk of developing prediabetes and diabetes. The study analyzed data from over 1.2 million participants, revealing that individuals who use e-cigarettes are 7% more likely to develop prediabetes, while traditional smokers face a 15% increased risk. Those who indulge in both habits simultaneously face the highest risk, with a 28% greater chance of developing prediabetes. Furthermore, users of both products also show increased odds of being diagnosed with diabetes,
highlighting the compounded health dangers.
The research emphasizes that e-cigarettes, often marketed as a safer alternative to smoking, may conceal hidden health risks, particularly affecting metabolic health and insulin resistance. The findings are especially concerning among vulnerable groups such as Hispanic, Black, and lower-income populations, who exhibit higher susceptibility.
Additional factors aggravating the risk include being overweight or obese, with heavier body mass index correlating with worse outcomes. Regular physical activity was found to reduce the risk of prediabetes by 8%, suggesting lifestyle modifications could mitigate some adverse effects.
These insights underscore the importance of public health initiatives aimed at reducing tobacco and e-cigarette use to curb the rising prevalence of diabetes and improve overall metabolic health.
Source: https://medicalxpress.com/news/2025-09-vaping-diabetes.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
First Clinical Trial Launches for Therapeutic Hepatitis B Vaccine
A groundbreaking therapeutic vaccine for chronic hepatitis B has entered human clinical trials, promising a potential new treatment to cure the disease and improve global health outcomes. Developed by researchers at the Technical University Munich, TherVacB aims to activate the immune system and target multiple strains of the virus.
Certain Metals and Sulfates in Air Pollution May Significantly Increase Asthma Hospitalizations
New research identifies nickel, vanadium, and sulfate particles in air pollution as key factors increasing asthma hospitalization risks. Targeted pollution control can reduce severe asthma attacks.
promising new investigational treatment shows potential for Crohn's disease remission
A new investigational therapy targeting TL1A shows significant potential to induce remission in Crohn's disease, offering hope for better treatment options. Recent studies highlight rapid response and possible effects on fibrosis crucial in disease management.
New Study Links Mitochondrial Dysfunction to Cognitive Decline in Neurodegenerative Diseases
A new study demonstrates that mitochondrial dysfunction plays a causal role in cognitive decline associated with neurodegenerative diseases, offering promising therapeutic targets. source: https://medicalxpress.com/news/2025-08-neurodegenerative-diseases-causal-link-mitochondrial.html